Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

This study has been completed.
Sponsor:
Information provided by:
Frederiksberg University Hospital
ClinicalTrials.gov Identifier:
NCT00376610
First received: September 14, 2006
Last updated: July 3, 2007
Last verified: July 2007

September 14, 2006
July 3, 2007
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00376610 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty
Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty

ASR/Re-cap versus 28 MoM

Not Provided
Interventional
Phase 4
Allocation: Non-Randomized
Endpoint Classification: Pharmacokinetics/Dynamics Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Bearings
Device: ASR/Re-cap
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Clinical diagnosis of THA
  • ASA I-II
  • Willing to return for follow-up evaluations

Exclusion Criteria:

  • Collum femurs < 2 cm
  • Cysts > 1 cm
  • Caput necrose
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00376610
KF1127957
Not Provided
Not Provided
Frederiksberg University Hospital
Not Provided
Study Director: Arne Borgwardt Frederiksberg Univesity Hospital
Frederiksberg University Hospital
July 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP